Suppr超能文献

随访时壁强化增加可预测后续动脉瘤生长。

Increased Wall Enhancement During Follow-Up as a Predictor of Subsequent Aneurysmal Growth.

机构信息

From the Department of Neuroradiology, University Hospital, Bordeaux, France (F.G.).

Department of Neuroradiology, Université Paris-Descartes-Sorbonne-Paris-Cité, IMABRAIN-INSERM-UMR1266, DHU-Neurovasc, Centre Hospitalier Sainte-Anne, Paris, France (W.B.H., G.B., D.T., L.L., C.R.-R., C.O., O.N., M.E.).

出版信息

Stroke. 2020 Jun;51(6):1868-1872. doi: 10.1161/STROKEAHA.119.028431. Epub 2020 May 13.

Abstract

Background and Purpose- Absence of arterial wall enhancement (AWE) of unruptured intracranial aneurysms (UIA) has shown promise at predicting which aneurysms will not rupture. We here tested the hypothesis that increased enhancement during follow-up (increased intensity, extension, or thickness or appearance of de novo enhancement), assessed using vessel wall magnetic resonance imaging, was associated with higher rates of subsequent growth. Methods- Patients with UIA were included between 2012 and 2018. Two readers independently rated AWE modification on 3T vessel wall magnetic resonance imaging, and morphological changes on time-of-flight magnetic resonance angiography during follow-up. Results- A total of 129 patients harboring 145 UIA (mean size 4.1 mm) met study criteria, of which 12 (8.3%) displayed morphological growth at 2 years. Of them, 8 demonstrated increased AWE during follow-up before or concurrently to morphological growth, and 4 had preexisting AWE that remained stable before growth. In the remaining 133 (nongrowing) UIAs, no AWE modifications were found. In multivariable analysis, increased AWE, not size, was associated with UIA growth (relative risk, 26.1 [95% CI, 7.4-91.7], <0.001). Sensitivity, specificity, positive predictive value, and negative predictive value for UIA growth of increased AWE during follow-up were, respectively, of 67%, 100%, 96%, and 100%. Conclusions- Increased AWE during follow-up of conservatively managed UIAs predicts aneurysm growth over a 2-year period. This may impact UIA management towards closer monitoring or preventive treatment. Replication in a different setting is warranted.

摘要

背景与目的-未破裂颅内动脉瘤(UIA)的动脉壁增强(AWE)缺失已显示出预测哪些动脉瘤不会破裂的潜力。我们在此测试了假设,即使用血管壁磁共振成像评估的随访期间增强增加(增强的强度、延伸、厚度或新出现的增强)与随后的生长率更高相关。

方法-2012 年至 2018 年间纳入了患有 UIA 的患者。两名读者分别在 3T 血管壁磁共振成像上独立评估 AWE 改变,并在随访期间进行时飞越磁共振血管造影的形态变化。

结果-共有 129 名患者携带 145 个 UIA(平均大小 4.1mm)符合研究标准,其中 12 个(8.3%)在 2 年内显示出形态生长。其中,8 个在形态生长之前或同时显示出 AWE 增加,4 个在生长前存在稳定的 AWE。在其余 133 个(非生长)UIA 中,未发现 AWE 改变。在多变量分析中,AWE 增加,而不是大小,与 UIA 生长相关(相对风险,26.1[95%CI,7.4-91.7],<0.001)。随访期间 AWE 增加对 UIA 生长的敏感性、特异性、阳性预测值和阴性预测值分别为 67%、100%、96%和 100%。

结论-保守治疗的 UIA 随访期间 AWE 增加可预测 2 年内的动脉瘤生长。这可能会影响 UIA 的管理,以便进行更密切的监测或预防性治疗。在不同环境中进行复制是有必要的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验